drugset / Trial / NCT03907098
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying endostar in combination with chemotherapy as a possible treatment for HER-2 negative advanced breast cancer.
Timeline
- Start
- 2016-06-30
- Primary completion
- 2019-12-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | 15 mg/m2 | Intravenous |